Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
Phase 1
Not yet recruiting
- Conditions
- Herpes Zoster
- Interventions
- Biological: Recombinant Zoster VaccineBiological: PlaceboBiological: Zoster Vaccine Recombinant, Adjuvanted
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05718037
Phase β Clinical Trial of a Candidate COVID-19 Vaccine
Phase 1
Not yet recruiting
- Conditions
- COVID-19
- Interventions
- Biological: Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05706324
- Locations
- πΈπ¬
National University Hospital, Singapore, Singapore
Phase I Clinical Trial of a Candidate HPV Vaccine
Phase 1
Not yet recruiting
- Conditions
- Human Papillomavirus Infection
- Interventions
- Biological: Human papillomavirus (HPV) VaccineBiological: Placebo
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2023-01-06
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05672966
- Locations
- π¦πΊ
Paratus Clinical Research Canberra, Canberra, Australia
Phase I Clinical Trial of a Candidate PCV13 in Healthy People
Phase 1
Recruiting
- Conditions
- Pneumococcal Infections
- Interventions
- Biological: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 264
- Registration Number
- NCT05602480
- Locations
- π¨π³
Xiangtan Maternal and Child Health Hospital, Xiangtan, Hunan, China
Β© Copyright 2025. All Rights Reserved by MedPath